Can the conventional sextant prostate biopsy accurately predict unilateral prostate cancer in low-risk, localized, prostate cancer?
- 30 April 2011
- journal article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 29 (2), 166-170
- https://doi.org/10.1016/j.urolonc.2009.03.011
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Pathologic stage T2a and T2b prostate cancer in the recent prostate‐specific antigen era: Implications for unilateral ablative therapyThe Prostate, 2008
- “Male Lumpectomy”: Focal Therapy for Prostate Cancer Using CryoablationUrology, 2007
- Focal Cryosurgery: Encouraging Health Outcomes for Unifocal Prostate CancerUrology, 2007
- Rationale for a “Male Lumpectomy,” a Prostate Cancer Targeted Approach Using Cryoablation: Results in 21 Patients with at Least 2 Years of Follow-UpCardioVascular and Interventional Radiology, 2007
- Prostate cancer laterality as a rationale of focal ablative therapy for the treatment of clinically localized prostate cancerCancer, 2007
- Micro-Focal Prostate Cancer: A Comparison of Biopsy and Radical Prostatectomy Specimen FeaturesEuropean Urology, 2005
- Anatomic distribution and pathologic characterization of small-volume prostate cancer (<0.5 ml) in whole-mount prostatectomy specimensLaboratory Investigation, 2005
- The Changing Face of Low-Risk Prostate Cancer: Trends in Clinical Presentation and Primary ManagementJournal of Clinical Oncology, 2004
- Prostate cancer sampled on sextant needle biopsy: significance of cancer on multiple cores from different areas of the prostateUrology, 1999
- Random Systematic Versus Directed Ultrasound Guided Transrectal Core Biopsies of the ProstateJournal of Urology, 1989